Post-Collection Sample Storage Guidance for Molecular, Culture, and Environmental Workflows
Proper handling and storage of samples after collection are essential to preserving integrity for molecular analyses (e.g., PCR, sequencing), culture-based methods (viability), and other biochemical or optical techniques.
This guidance applies to samples processed using InnovaPrep workflows, including Wet Foam Elution (WFE) eluates, air samples collected on electret filters, and liquid concentrates.
Overview: Why Sample Storage Matters
Changes in target recovery during storage are driven by well-established biological processes, including nucleic acid degradation, enzymatic activity, and loss of organism viability. These effects are independent of collection platform and are typical across standard aqueous buffer systems.
InnovaPrep workflows utilize aqueous buffers (e.g., Tris- or PBS-based formulations with surfactants such as Tween) that support efficient recovery and downstream compatibility. However, these are not intended as long-term preservation media.
Key takeaway: Reliable performance depends on proper handling, storage conditions, and validation for your specific organism, matrix, and analytical method.
Sample Types and Their Impact on Storage
Dry-Phase Samples (Filter-Based Air Sampling)
Dry samples—such as those collected on electret filters—limit enzymatic activity prior to processing but remain sensitive to environmental conditions.
Considerations:
- Stability influenced by humidity, temperature, and time to extraction
- Recovery depends on filter media and elution efficiency
- Electrostatic filters enhance capture but require proper handling
Best practice: Define and validate time-to-elution and interim storage conditions as part of your workflow.
Liquid-Phase Samples (Eluates and Concentrates)
Liquid samples, including WFE eluates and concentrated samples, are more susceptible to degradation pathways.
Considerations:
- Exposure to nucleases and proteases
- Potential adsorption and biological activity
- Increased sensitivity to temperature fluctuations
Best practice: Maintain cold conditions and minimize time to processing or stabilization.
Storage Recommendations
Dry Filter Samples
|
Timeframe |
Temperature |
Notes |
|
Short-term (<7 days) |
4°C |
Store in clean, dry containers to minimize moisture and electrostatic loss |
|
Extended (>7 days, molecular) |
–20°C or –80°C |
Freezing improves nucleic acid stability |
|
Long-term |
–80°C |
Recommended for archival storage |
Liquid Samples (WFE Eluates & Concentrates)
|
Timeframe |
Temperature |
Notes |
|
Same day |
4°C |
Ideal for immediate downstream processing |
|
24–48 hours |
4°C or –20°C |
Avoid repeated freeze–thaw cycles |
|
Intermediate (2 days–12 weeks) |
–80°C |
Maximizes nucleic acid stability |
|
Long-term |
–80°C |
Recommended for archival storage |
Molecular vs. Viability Considerations
|
Factor |
Molecular Detection (PCR/Sequencing) |
Viability / Culture |
|
Freezing |
Generally acceptable, often preferred |
May reduce recovery due to cell damage |
|
Freeze–thaw cycles |
Should be minimized |
Strongly discouraged |
|
Storage duration |
Longer at –80°C |
Short durations recommended |
Sample Inactivation (When Required)
When handling potentially infectious material, inactivation may be necessary.
Examples include:
- Dry heat (≤90°C) for viruses on dry filters
- Chemical or media-based inactivation (e.g., viral transport media) for liquid samples
All inactivation methods should be validated for the specific organism and matrix, particularly when viable targets are relevant.
Handling Best Practices
- Maintain cold chain from collection through analysis
- Elute samples promptly when feasible
- Aliquot samples to reduce freeze–thaw cycles
- Use nuclease-free consumables for molecular workflows
- Consider RNase/DNase inhibitors when compatible
Improper handling can compromise nucleic acid integrity and analytical performance.
Shipping and Transport
To preserve sample integrity during transport:
Recommended:
- Ship frozen samples on dry ice (≤ –50°C)
- Ship refrigerated samples at 2–8°C when appropriate
- Use insulated, temperature-stable packaging
Avoid:
- Temperature excursions
- Repeated thaw/refreeze cycles
Include proper chain-of-custody and sample tracking documentation (e.g., sample ID, collection metadata).
Validating Sample Stability
Validation ensures reliable detection and quantitation under your specific conditions.
Suggested approach:
- Spike known targets pre- or post-elution
- Evaluate across timepoints and storage conditions
- Measure Ct shift, recovery percentage, and viability
Example acceptance criteria:
- ≤1 Ct shift (molecular assays)
- ≥70–90% recovery
- Consistent replicate performance
Matrix-Specific Considerations
Sample composition and environmental exposure can influence results.
Factors include:
- Humidity and temperature exposure
- PCR inhibitors (e.g., organic material)
- Residual disinfectants
- Proteases and nucleases
These should be considered when developing and validating storage protocols.
Summary: Best Practices for Sample Storage
- Maintain cold chain throughout workflow
- Store long-term samples at –80°C
- Minimize freeze–thaw cycles
- Process samples promptly when possible
- Validate conditions for your specific application
Final Note
This guidance provides general best practices for sample handling and storage and does not replace assay-specific validation. Performance should always be evaluated within the context of the organism, matrix, and analytical method used.